In patients, POM121 is overexpressed in cancers of the upper gastrointestinal tract [21–23], the lungs [24] and in CRC [25], and therein associated with higher tumor (TNM) staging, metastasis [26] and poor prognosis, while POM121 gene fusions present in leukemia [27]. The gene discussed is POM121; the disease is cancer.